Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Amortizatization of Intangibles: 2018-2025

Historic Amortizatization of Intangibles for Organogenesis Holdings (ORGO) over the last 8 years, with Sep 2025 value amounting to $842,000.

  • Organogenesis Holdings' Amortizatization of Intangibles rose 0.96% to $842,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year decrease of 5.66%. This contributed to the annual value of $8.3 million for FY2024, which is 3.28% up from last year.
  • Organogenesis Holdings' Amortizatization of Intangibles amounted to $842,000 in Q3 2025, which was up 0.12% from $841,000 recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Amortizatization of Intangibles registered a high of $2.2 million during Q1 2024, and its lowest value of $834,000 during Q2 2024.
  • Its 3-year average for Amortizatization of Intangibles is $1.5 million, with a median of $1.2 million in 2023.
  • As far as peak fluctuations go, Organogenesis Holdings' Amortizatization of Intangibles skyrocketed by 52.33% in 2021, and later crashed by 32.14% in 2024.
  • Organogenesis Holdings' Amortizatization of Intangibles (Quarterly) stood at $1.8 million in 2021, then dropped by 0.49% to $1.8 million in 2022, then grew by 16.43% to $2.1 million in 2023, then fell by 6.98% to $2.0 million in 2024, then increased by 0.96% to $842,000 in 2025.
  • Its Amortizatization of Intangibles stands at $842,000 for Q3 2025, versus $841,000 for Q2 2025 and $2.0 million for Q1 2025.